The Journal of Heart and Lung Transplantation
Volume 24, Issue 11 , Pages 1721-1729 , November 2005

Role of Toll-Like Receptor–Driven Innate Immunity in Thoracic Organ Transplantation

  • Daniel R. Goldstein, MD

      Affiliations

    • Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut
    • Corresponding Author InformationReprint requests: Daniel R. Goldstein, MD, Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, 3 FMP, P.O. Box 208017, New Haven, Connecticut 06520-8018. Telephone: 203-785-3271. Fax: 203-785-7567.
  • ,
  • Scott M. Palmer, MD

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Received 26 August 2004 ,Revised 30 November 2004 ,Accepted 7 January 2005.

References 

  1. Akira S . Mammalian Toll-like receptors . Curr Opin Immunol . 2003;15:5–11
  2. Zhang D , Zhang G , Hayden MS , et al.   A Toll-like receptor that prevents infection by uropathogenic bacteria . Science . 2004;303:1522–1526
  3. Heil F , Hemmi H , Hochrein H , et al.   Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8 . Science . 2004;303:1526–1529
  4. Diebold SS , Kaisho T , Hemmi H , Akira S , Reis e Sousa C . Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA . Science . 2004;303:1529–1531
  5. Lund J , Sato A , Akira S , Medzhitov R , Iwasaki A . Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells . J Exp Med . 2003;198:513–520
  6. Medzhitov R . Toll-like receptors and innate immunity . Nat Rev Immunol . 2001;1:135–145
  7. Schnare M , Barton GM , Holt AC , et al.   Toll-like receptors control activation of adaptive immune responses . Nat Immunol . 2001;2:947–950
  8. Barton GM , Medzhitov R . Toll-like receptor signaling pathways . Science . 2003;300:1524–1525
  9. Luster AD . The role of chemokines in linking innate and adaptive immunity . Curr Opin Immunol . 2002;14:129–135
  10. Kaisho T , Takeuchi O , Kawai T , Hoshino K , Akira S . Endotoxin-induced maturation of MyD88-deficient dendritic cells . J Immunol . 2001;166:5688–5694
  11. Fitzgerald KA , Palsson-McDermott EM , Bowie AG , et al.   Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction . Nature . 2001;413:78–83
  12. Horng T , Barton GM , Medzhitov R . TIRAP (an adapter molecule in the Toll signaling pathway) . Nat Immunol . 2001;2:835–841
  13. Yamamoto M , Sato S , Hemmi H , et al.   Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 . Nature . 2002;420:324–329
  14. Horng T , Barton GM , Flavell RA , Medzhitov R . The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors . Nature . 2002;420:329–333
  15. Doyle S , Vaidya S , O’Connell R , et al.   IRF3 mediates a TLR3/TLR4-specific antiviral gene program . Immunity . 2002;17:251–263
  16. Oshiumi H , Matsumoto M , Funami K , Akazawa T , Seya T . TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction . Nat Immunol . 2003;4:161–167
  17. Yamamoto M , Sato S , Mori K , et al.   Cutting edge (a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling) . J Immunol . 2002;169:6668–6672
  18. Yamamoto M , Sato S , Hemmi H , et al.   Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway . Science . 2003;301:640–643
  19. Hoebe K , Du X , Georgel P , et al.   Identification of LPS2 as a key transducer of MyD88-independent TIR signalling . Nature . 2003;424:743–748
  20. Hoebe K , Janssen EM , Kim SO , et al.   Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways . Nat Immunol . 2003;4:1223–1229
  21. Yamamoto M , Sato S , Hemmi H , et al.   TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway . Nat Immunol . 2003;4:1144–1150
  22. O’Neill LAJ , Fitzgerald KA , Bowie AG . The Toll-IL-1 receptor adaptor family grows to five members . Trends Immunol . 2003;24:286–289
  23. Kobayashi K , Hernandez LD , Galan JE , et al.   IRAK-M is a negative regulator of Toll-like receptor signaling . Cell . 2002;110:191–202
  24. Kinjyo I , Hanada T , Inagaki-Ohara K , et al.   SOCS1/JAB is a negative regulator of LPS-induced macrophage activation . Immunity . 2001;17:583–591
  25. Burns K , Janssens S , Brissoni B , et al.   Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 . J Exp Med . 2003;197:263–268
  26. Wald D , Qin J , Zhao Z , et al.   SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling . Nat Immunol . 2003;4:920–927
  27. Jankovic D , Kullberg MC , Hieny S , et al.   In the absence of IL-12, CD4(+) T cell responses to intracellular pathogensfail to default to a Th2 pattern and are host protective in an IL-10(–/–) setting . Immunity . 2002;16:429–439
  28. Eisenbarth SC , Piggott DA , Huleatt JW , et al.   Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen . J Exp Med . 2002;196:1645–1651
  29. Redecke V , Hacker H , Datta SK , et al.   Cutting edge (activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma) . J Immunol . 2004;172:2739–2743
  30. Supajatura V , Ushio H , Nakao A , et al.   Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity . J Clin Invest . 2002;109:1351–1359
  31. Didierlaurent A , Ferrero I , Otten LA , et al.   Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response . J Immunol . 2004;172:6922–6930
  32. Dabbagh K . Toll-like receptors and T-helper-1/T-helper-2 responses . Curr Opin Infect Dis . 2003;16:199–204
  33. Guillot L , Balloy V , McCormack FX , et al.   Cutting edge (the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4) . J Immunol . 2002;168:5989–5992
  34. Asea A , Kraeft SK , Kurt-Jones EA , et al.   HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine . Nat Med . 2000;6:435–442
  35. Asea A , Rehli M , Kabingu E , et al.   Novel signal transduction pathway utilized by extracellular HSP70 (role of Toll-like receptor (TLR) 2 and TLR4) . J Biol Chem . 2002;277:15028–15034
  36. Johnson GB , Brunn GJ , Kodaira Y , Platt JL . Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4 . J Immunol . 2002;168:5233–5239
  37. Ohashi K , Burkart V , Flohe S , Kolb H . Cutting edge (heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex) . J Immunol . 2000;164:558–561
  38. Termeer C , Benedix F , Sleeman J , et al.   Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4 . J Exp Med . 2002;195:99–111
  39. Leadbetter EA , Rifkin IR , Hohlbaum AM , et al.   Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors . Nature . 2002;416:603–607
  40. Gaston JS . Heat shock proteins and innate immunity . Clin Exp Immunol . 2002;127:1–3
  41. Wallin RP , Lundqvist A , More SH , et al.   Heat-shock proteins as activators of the innate immune system . Trends Immunol . 2002;23:130–135
  42. Palmer S , Henshaw N , Howell D , et al.   Community respiratory viral infection in adult lung transplant recipients . Chest . 1998;113:944–950
  43. Garantziotis S , Howell DN , McAdams HP , et al.   Influenza pneumonia in lung transplant recipients (clinical features and association with bronchiolitis obliterans syndrome) . Chest . 2001;119:1277–1280
  44. Khalifah AP , Hachem RR , Chakinala MM , et al.   Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death . Am J Respir Crit Care Med . 2004;170:181–187
  45. el-Sawy T , Fahmy NM , Fairchild RL . Chemokines (directing leukocyte infiltration into allografts) . Curr Opin Immunol . 2002;14:562–568
  46. Pockley AG . Heat shock proteins, anti-heat shock protein reactivity and allograft rejection . Transplantation . 2001;71:1503–1507
  47. Goldstein DR , Tesar BM , Akira S , Lakkis FG . Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection . J Clin Invest . 2003;111:1571–1578
  48. Samstein B , Johnson GB . Toll-like receptor-4 and allograft responses . Transplantation . 2004;15:475–477
  49. Tesar BM , Zhang J , Li Q , Goldstein DR . TH1 Immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a Toll like receptor signal adaptor protein . Am J Transplant . 2004;2004:4; 1429–39
  50. Arbour NC , Lorenz E , Schutte BC , et al.   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans . Nat Genet . 2000;25:187–191
  51. Kiechl S , Lorenz E , Reindl M , et al.   Toll-like receptor 4 polymorphisms and atherogenesis . N Engl J Med . 2002;347:185–192
  52. Agnese DM , Calvano JE , Hahm SJ , et al.   Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections . J Infect Dis . 2002;186:1522–1525
  53. Lorenz E , Hallman M , Marttila R , Haataja R , Schwartz DA . Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population . Pediatr Res . 2002;52:373–376
  54. Palmer SM , Burch LH , Davis RD , et al.   The role of innate immunity in acute allograft rejection after lung transplantation . Am J Respir Crit Care Med . 2003;168:628–632
  55. Palmer SM , Burch LH , Herczyk WF , et al.   Role of TLR4 in acute pulmonary allograft rejection . Am J Respir Crit Care Med . 2004;169:A269
  56. Hawn TR , Verbon A , Lettinga KD , et al.   A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaire’s disease . J Exp Med . 2003;198:1563–1572
  57. Lorenz E , Mira JP , Cornish KL , Arbour NC , Schwartz DA . A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection . Infect Immun . 2000;68:6398–6401
  58. Kondo T , Morita K , Watarai Y , et al.   Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells . Transplantation . 2000;69:969–977
  59. Manilay JO , Sykes M . Natural killer cells and their role in graft rejection . Curr Opin Immunol . 1998;10:532–538
  60. Fox A , Koulmanda M , Mandel TE , van Rooijen N , Harrison LC . Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice . Transplantation . 1998;66:1407–1416
  61. Fox A , Mountford J , Braakhuis A , Harrison LC . Innate and adaptive immune responses to nonvascular xenografts (evidence that macrophages are direct effectors of xenograft rejection) . J Immunol . 2001;166:2133–2140
  62. Maier S , Tertilt C , Chambron N , et al.   Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28–/– mice . Nat Med . 2002;7:557–562
  63. Pratt JR , Basheer SA , Sacks SH . Local synthesis of complement component C3 regulates acute renal transplant rejection . Nat Med . 2002;8:582–587
  64. Qian Z , Wasowska BA , Behrens E , et al.   C6 Produced by macrophages contributes to cardiac allograft rejection . Am J Pathol . 1999;155:1293–1302
  65. Bjorkbacka H , Kunjathoor VV , Moore KJ , et al.   Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways . Nat Med . 2004;10:416–421
  66. Michelsen KS , Wong MH , Shah PK , et al.   Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E . Proc Natl Acad Sci . 2004;101:10679–10684
  67. Oyama J-i , Blais C , Liu X , Pu M , et al.   Reduced myocardial ischemia–reperfusion injury in Toll-like receptor 4-deficient Mice . Circulation . 2004;109:784–789
  68. Shishido T , Nozaki N , Yamaguchi S , et al.   Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction . Circulation . 2003;108:2905–2910
  69. Fan J , Frey RS , Malik AB . TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase . J Clin Invest . 2003;112:1234–1243
  70. Land W . Postischemic reperfusion injury to allografts—a case for ‘innate immunity’? . Eur Surg Res . 2002;34:160–169
  71. Brown GD , Herre J , Williams DL , et al.   Dectin-1 mediates the biological effects of beta-glucans . J Exp Med . 2003;197:1119–1124
  72. Chamaillard M , Hashimoto M , Horie Y , et al.   An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid . Nat Immunol . 2003;4:702–707
  73. Girardin SE , Boneca IG , Carneiro LA , et al.   NOD1 detects a unique muropeptide from gram-negative bacterial peptidoglycan . Science . 2003;300:1584–1587
  74. Gordon S . Pattern recognition receptors (doubling up for the innate immune response) . Cell . 2002;111:927–930
  75. Garred P , Pressler T , Madsen HO , et al.   Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis . J Clin Invest . 1999;104:431–437
  76. Lee SJ , Evers S , Roeder D , et al.   Mannose receptor–mediated regulation of serum glycoprotein homeostasis . Science . 2002;295:1898–1901
  77. Lee SJ , Zheng NY , Clavijo M , Nussenzweig MC . Normal host defense during systemic candidiasis in mannose receptor-deficient mice . Infect Immun . 2003;71:437–445
  78. Wekerle T . Transplantation tolerance induced by mixed chimerism . J Heart Lung Transplant . 2001;20:816–823
  79. Ibrahim JE , Sweet SC , Flippin M , et al.   Rejection is reduced in thoracic organ recipients when transplanted in the first year of life . J Heart Lung Transplant . 2002;21:311–318

PII: S1053-2498(05)00061-6

doi: 10.1016/j.healun.2005.01.003

The Journal of Heart and Lung Transplantation
Volume 24, Issue 11 , Pages 1721-1729 , November 2005